All PlansCoverageLow impact
Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Cardiothoracic Surgery·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy confirms that progenitor cell therapy (stem cell therapy) for damaged heart muscle remains investigational and non-covered. The policy was recently updated with a new policy number (L.2.02.413) but the coverage determination remains unchanged - these treatments are still considered experimental.
Action Required
Update billing system to reference new policy number L.2.02.413 for progenitor cell therapy denials. Ensure staff are aware that all stem cell procedures for heart conditions (CPT codes 38204-38241 and HCPCS M0075) remain non-covered as investigational. Continue to inform patients these treatments are experimental and not covered by insurance.